Ibotta (IBTA) Financials

Ibotta logo
$57.65 +0.06 (+0.10%)
As of 11/16/2026 03:58 PM Eastern
Annual Income Statements for Ibotta

Annual Income Statements for Ibotta

This table shows Ibotta's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders
-55 38 69 3.58
Consolidated Net Income / (Loss)
-55 38 69 3.58
Net Income / (Loss) Continuing Operations
-55 38 69 3.58
Total Pre-Tax Income
-55 44 24 9.85
Total Operating Income
-40 56 28 -0.84
Total Gross Profit
165 276 317 271
Total Revenue
211 320 367 342
Operating Revenue
211 320 367 342
Total Cost of Revenue
46 44 50 71
Operating Cost of Revenue
46 44 50 71
Total Operating Expenses
205 220 289 272
Selling, General & Admin Expense
49 52 83 88
Marketing Expense
110 115 139 119
Research & Development Expense
43 50 63 61
Depreciation Expense
3.05 3.66 3.98 3.91
Total Other Income / (Expense), net
-14 -12 -3.43 11
Interest Expense
0.00 0.00 9.69 0.00
Interest & Investment Income
-5.31 -6.88 9.41 11
Other Income / (Expense), net
-8.98 -5.06 -3.16 -0.09
Income Tax Expense
0.26 5.93 -44 6.27
Basic Earnings per Share
($6.33) $4.26 $2.85 $0.13
Weighted Average Basic Shares Outstanding
8.67M 8.95M 24.12M 28.37M
Diluted Earnings per Share
($6.33) $1.42 $2.56 $0.12
Weighted Average Diluted Shares Outstanding
8.67M 26.92M 26.86M 30.10M
Weighted Average Basic & Diluted Shares Outstanding
- - 31.02M 24.35M

Quarterly Income Statements for Ibotta

This table shows Ibotta's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Total Costs & Expenses
- - - - - - 64 - - - 73
Net Income / (Loss) Attributable to Common Shareholders
9.30 -34 17 76 0.56 2.49 1.53 -1.00 -10 -1.23 -3.50
Consolidated Net Income / (Loss)
9.30 -34 17 76 0.56 2.49 1.53 -1.00 -10 -1.23 -3.50
Net Income / (Loss) Continuing Operations
9.30 -34 17 76 0.56 2.49 1.53 -1.00 -10 -1.23 -3.50
Total Pre-Tax Income
12 -30 25 17 0.48 3.87 5.25 0.24 -9.35 -0.53 6.08
Total Operating Income
16 -22 21 13 -2.80 1.24 2.37 -1.64 -11 -1.88 4.72
Total Gross Profit
72 76 86 83 67 68 66 70 63 70 78
Total Revenue
82 88 99 98 85 86 83 89 82 89 98
Operating Revenue
82 88 99 98 85 86 83 89 82 89 98
Total Cost of Revenue
11 12 12 15 17 18 17 19 19 19 20
Operating Cost of Revenue
11 12 12 15 17 18 17 19 19 19 20
Total Operating Expenses
56 97 66 70 70 67 64 71 74 72 73
Selling, General & Admin Expense
13 29 21 20 21 22 22 22 24 22 23
Marketing Expense
28 50 28 33 30 29 27 34 34 33 32
Research & Development Expense
14 18 16 16 18 15 14 14 15 15 16
Depreciation Expense
0.98 1.05 1.07 0.89 0.97 1.05 0.64 1.26 1.56 1.85 2.10
Total Other Income / (Expense), net
-3.51 -8.37 4.42 4.03 3.29 2.63 2.89 1.89 1.48 1.35 1.36
Interest & Investment Income
-1.81 2.67 4.44 4.11 3.69 2.64 2.51 1.95 1.51 1.36 1.35
Other Income / (Expense), net
-1.70 -1.41 -0.02 -0.03 -0.40 -0.01 0.38 -0.06 -0.03 -0.01 0.01
Income Tax Expense
3.10 3.94 7.89 -59 -0.07 1.38 3.72 1.25 0.97 0.70 9.59
Basic Earnings per Share
$1.00 ($1.32) $0.56 $2.61 $0.02 $0.09 $0.05 ($0.03) ($0.43) ($0.05) ($0.15)
Weighted Average Basic Shares Outstanding
9.31M 25.66M 30.66M 24.12M 30.78M 28.48M 28.00M 28.37M 24.15M 23.28M 23.35M
Diluted Earnings per Share
$0.33 ($1.32) $0.51 $3.04 $0.02 $0.08 $0.05 ($0.03) ($0.43) ($0.05) ($0.15)
Weighted Average Diluted Shares Outstanding
28.36M 25.66M 33.57M 26.86M 33.22M 30.43M 29.38M 30.10M 24.15M 23.28M 23.35M
Weighted Average Basic & Diluted Shares Outstanding
30.45M 30.64M 30.63M 31.02M 28.45M 28.40M 26.58M 24.35M 23.27M 23.17M 23.43M

Annual Cash Flow Statements for Ibotta

This table details how cash moves in and out of Ibotta's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents
-18 45 287 -163
Net Cash From Operating Activities
-56 23 116 95
Net Cash From Continuing Operating Activities
-56 23 116 95
Net Income / (Loss) Continuing Operations
-55 38 69 3.58
Consolidated Net Income / (Loss)
-55 38 69 3.58
Depreciation Expense
6.32 6.66 8.08 8.32
Amortization Expense
2.57 3.31 1.06 0.15
Non-Cash Adjustments To Reconcile Net Income
29 87 112 69
Changes in Operating Assets and Liabilities, net
-39 -112 -74 14
Net Cash From Investing Activities
-36 20 -10 -34
Net Cash From Continuing Investing Activities
-36 20 -10 -34
Purchase of Property, Plant & Equipment
-8.26 -8.23 -10 -34
Sale and/or Maturity of Investments
39 28 0.00 0.00
Net Cash From Financing Activities
74 2.39 181 -224
Net Cash From Continuing Financing Activities
74 2.39 181 -224
Repayment of Debt
-5.57 -0.01 -0.90 -0.00
Repurchase of Common Equity
-0.03 -0.65 -37 -233
Issuance of Common Equity
0.00 0.00 209 3.22
Other Financing Activities, net
1.14 3.05 10 5.70
Cash Interest Paid
3.52 5.49 2.58 0.25
Cash Income Taxes Paid
0.07 4.11 13 5.15

Quarterly Cash Flow Statements for Ibotta

This table details how cash moves in and out of Ibotta's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
Net Change in Cash & Equivalents
17 238 23 8.42 -52 -47 -27 -37 -22 -16 1.72
Net Cash From Operating Activities
19 35 40 22 20 26 22 28 30 13 22
Net Cash From Continuing Operating Activities
19 35 40 22 20 26 22 28 30 13 22
Net Income / (Loss) Continuing Operations
9.30 -34 17 76 0.56 2.49 1.53 -1.00 -10 -1.23 -3.50
Consolidated Net Income / (Loss)
9.30 -34 17 76 0.56 2.49 1.53 -1.00 -10 -1.23 -3.50
Depreciation Expense
1.91 2.11 2.14 1.92 2.17 2.45 1.24 2.47 2.87 3.37 3.72
Amortization Expense
0.83 0.20 0.01 0.02 0.04 0.04 0.04 0.04 0.04 0.04 0.04
Non-Cash Adjustments To Reconcile Net Income
1.09 70 30 11 6.88 23 17 22 16 31 25
Changes in Operating Assets and Liabilities, net
6.25 -3.06 -9.92 -67 10 -2.05 1.85 4.21 21 -20 -2.85
Net Cash From Investing Activities
-2.47 -2.32 -2.87 -2.55 -4.97 -7.00 -11 -11 -7.06 -5.20 -5.17
Net Cash From Continuing Investing Activities
-2.47 -2.32 -2.87 -2.55 -4.97 -7.00 -11 -11 -7.06 -5.20 -5.17
Purchase of Property, Plant & Equipment
-2.47 -2.32 -2.87 -2.55 -4.97 -7.00 -11 -11 -7.09 -5.20 -5.17
Net Cash From Financing Activities
0.01 206 -13 -11 -67 -66 -38 -53 -45 -24 -15
Net Cash From Continuing Financing Activities
0.01 206 -13 -11 -67 -66 -38 -53 -45 -24 -15
Repurchase of Common Equity
-1.70 -3.94 -16 -16 -70 -70 -38 -55 -45 -26 -14
Other Financing Activities, net
1.80 2.91 2.70 2.76 2.73 2.58 0.16 0.24 -0.50 -0.01 -1.17
Cash Interest Paid
1.99 - 0.03 0.05 0.02 0.08 0.08 0.08 0.08 0.07 0.08
Cash Income Taxes Paid
- - 3.17 5.07 0.00 - 0.24 0.81 0.57 -0.09 0.12

Annual Balance Sheets for Ibotta

This table presents Ibotta's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2023 2024 2025
Period end date 12/31/2023 12/31/2024 12/31/2025
Total Assets
320 678 526
Total Current Assets
298 582 408
Cash & Equivalents
63 349 187
Accounts Receivable
226 221 209
Prepaid Expenses
9.31 11 13
Plant, Property, & Equipment, net
2.54 1.95 23
Total Noncurrent Assets
19 95 95
Noncurrent Deferred & Refundable Income Taxes
0.00 73 55
Other Noncurrent Operating Assets
6.06 5.33 40
Total Liabilities & Shareholders' Equity
320 678 526
Total Liabilities
292 221 238
Total Current Liabilities
198 204 208
Accounts Payable
8.94 7.16 11
Accrued Expenses
25 18 20
Current Deferred Revenue
87 79 68
Other Current Liabilities
77 100 109
Total Noncurrent Liabilities
94 17 31
Other Noncurrent Operating Liabilities
29 17 31
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
28 457 288
Total Preferred & Common Equity
28 457 288
Preferred Stock
0.00 0.00 0.00
Total Common Equity
28 457 288
Common Stock
237 629 692
Retained Earnings
-209 -140 -137
Other Equity Adjustments
- - -268

Quarterly Balance Sheets for Ibotta

This table presents Ibotta's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 3/31/2025 6/30/2025 9/30/2025 3/31/2026 6/30/2026 9/30/2026
Total Assets
322 556 598 639 601 569 480 485 494
Total Current Assets
300 534 576 528 483 455 361 366 377
Cash & Equivalents
79 318 341 297 251 223 165 148 150
Accounts Receivable
206 209 228 206 209 213 183 203 222
Prepaid Expenses
14 7.35 6.99 24 23 19 13 14 6.03
Plant, Property, & Equipment, net
2.39 2.27 2.06 4.44 9.04 20 23 23 23
Total Noncurrent Assets
20 20 20 107 109 94 96 97 94
Noncurrent Deferred & Refundable Income Taxes
- - - 73 74 56 54 53 49
Other Noncurrent Operating Assets
5.64 5.18 4.71 16 16 16 15 43 45
Total Liabilities & Shareholders' Equity
322 556 598 639 601 569 480 485 494
Total Liabilities
278 196 220 238 247 240 231 244 256
Total Current Liabilities
182 190 211 197 204 207 201 213 226
Accounts Payable
7.68 5.24 8.25 11 11 15 7.24 7.31 7.77
Accrued Expenses
15 17 19 15 18 17 20 19 22
Current Deferred Revenue
87 84 85 78 76 74 66 65 64
Other Current Liabilities
71 84 100 92 100 100 108 122 131
Total Noncurrent Liabilities
96 6.18 8.84 41 43 33 30 30 30
Other Noncurrent Operating Liabilities
31 6.18 8.84 25 25 25 30 30 30
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
44 360 378 401 354 330 249 242 238
Total Preferred & Common Equity
44 360 378 401 354 330 249 242 238
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
44 360 378 401 354 330 249 242 238
Common Stock
244 594 610 646 664 678 709 726 741
Retained Earnings
-200 -234 -217 -140 -137 -136 -147 -148 -152
Other Equity Adjustments
- - - - - - -313 -336 -350

Annual Metrics And Ratios for Ibotta

This table displays calculated financial ratios and metrics derived from Ibotta's official financial filings.

Metric 2022 2023 2024 2025
Period end date 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics
- - - -
Revenue Growth
0.00% 51.89% 14.75% -6.77%
EBITDA Growth
0.00% 250.76% -44.34% -77.77%
EBIT Growth
0.00% 203.34% -51.37% -103.77%
NOPAT Growth
0.00% 271.71% 61.72% -100.39%
Net Income Growth
0.00% 169.48% 80.34% -94.80%
EPS Growth
0.00% 122.43% 80.28% -95.31%
Operating Cash Flow Growth
0.00% 140.21% 410.29% -17.81%
Free Cash Flow Firm Growth
0.00% 0.00% -97.02% 1,022.56%
Invested Capital Growth
0.00% 0.00% 261.23% -6.09%
Revenue Q/Q Growth
0.00% 0.00% 0.00% -2.80%
EBITDA Q/Q Growth
0.00% 0.00% 0.00% -65.14%
EBIT Q/Q Growth
0.00% 0.00% 0.00% -106.81%
NOPAT Q/Q Growth
0.00% 0.00% 0.00% -100.73%
Net Income Q/Q Growth
0.00% 0.00% 0.00% -95.57%
EPS Q/Q Growth
0.00% 0.00% 0.00% -96.24%
Operating Cash Flow Q/Q Growth
0.00% 0.00% 0.00% 6.50%
Free Cash Flow Firm Q/Q Growth
0.00% 0.00% 0.00% 122.50%
Invested Capital Q/Q Growth
0.00% 0.00% 193.30% -4.91%
Profitability Metrics
- - - -
Gross Margin
78.08% 86.25% 86.35% 79.25%
EBITDA Margin
-19.17% 19.03% 9.23% 2.20%
Operating Margin
-19.13% 17.50% 7.60% -0.25%
EBIT Margin
-23.39% 15.92% 6.74% -0.27%
Profit (Net Income) Margin
-26.04% 11.91% 18.72% 1.04%
Tax Burden Percent
100.48% 86.53% 280.63% 36.31%
Interest Burden Percent
110.78% 86.48% 98.90% -1,054.28%
Effective Tax Rate
0.00% 13.47% -180.63% 63.69%
Return on Invested Capital (ROIC)
0.00% 325.37% 114.09% -0.29%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% -788.10% 119.62% -1.74%
Return on Net Nonoperating Assets (RNNOA)
0.00% -52.40% -85.75% 1.25%
Return on Equity (ROE)
0.00% 272.97% 28.33% 0.96%
Cash Return on Invested Capital (CROIC)
0.00% 125.37% 0.81% 5.99%
Operating Return on Assets (OROA)
0.00% 15.93% 4.96% -0.16%
Return on Assets (ROA)
0.00% 11.92% 13.77% 0.59%
Return on Common Equity (ROCE)
0.00% 272.97% 28.33% 0.96%
Return on Equity Simple (ROE_SIMPLE)
0.00% 136.48% 15.03% 0.00%
Net Operating Profit after Tax (NOPAT)
-28 48 78 -0.31
NOPAT Margin
-13.39% 15.14% 21.34% -0.09%
Net Nonoperating Expense Percent (NNEP)
0.00% 1,113.46% -5.53% 1.45%
Return On Investment Capital (ROIC_SIMPLE)
- 52.45% 17.14% -0.11%
Cost of Revenue to Revenue
21.92% 13.75% 13.65% 20.75%
SG&A Expenses to Revenue
23.33% 16.13% 22.53% 25.77%
R&D to Revenue
20.20% 15.62% 17.23% 17.84%
Operating Expenses to Revenue
97.22% 68.76% 78.75% 79.49%
Earnings before Interest and Taxes (EBIT)
-49 51 25 -0.93
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
-40 61 34 7.54
Valuation Ratios
- - - -
Price to Book Value (P/BV)
0.00 20.67 4.36 2.10
Price to Tangible Book Value (P/TBV)
0.00 38.28 4.52 2.29
Price to Revenue (P/Rev)
2.74 1.80 5.43 1.76
Price to Earnings (P/E)
0.00 15.15 29.00 169.01
Dividend Yield
0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 6.60% 3.45% 0.59%
Enterprise Value to Invested Capital (EV/IC)
0.00 19.45 15.28 4.13
Enterprise Value to Revenue (EV/Rev)
0.00 1.81 4.48 1.22
Enterprise Value to EBITDA (EV/EBITDA)
0.00 9.51 48.48 55.40
Enterprise Value to EBIT (EV/EBIT)
0.00 11.37 66.36 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 11.95 20.97 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 25.50 14.18 4.38
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 31.02 2,952.61 66.83
Leverage & Solvency
- - - -
Debt to Equity
0.00 2.31 0.00 0.00
Long-Term Debt to Equity
0.00 2.31 0.00 0.00
Financial Leverage
0.00 0.07 -0.72 -0.72
Leverage Ratio
0.00 11.45 2.06 1.62
Compound Leverage Factor
0.00 9.90 2.03 -17.04
Debt to Total Capital
0.00% 69.77% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
0.00% 69.77% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
0.00% 30.23% 100.00% 100.00%
Debt to EBITDA
0.00 1.06 0.00 0.00
Net Debt to EBITDA
0.00 0.03 0.00 0.00
Long-Term Debt to EBITDA
0.00 1.06 0.00 0.00
Debt to NOPAT
0.00 1.33 0.00 0.00
Net Debt to NOPAT
0.00 0.04 0.00 0.00
Long-Term Debt to NOPAT
0.00 1.33 0.00 0.00
Altman Z-Score
0.00 2.17 6.45 2.26
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - -
Current Ratio
0.00 1.51 2.85 1.96
Quick Ratio
0.00 1.46 2.79 1.90
Cash Flow Metrics
- - - -
Free Cash Flow to Firm (FCFF)
0.00 19 0.56 6.25
Operating Cash Flow to CapEx
-683.76% 276.08% 1,136.33% 277.74%
Free Cash Flow to Firm to Interest Expense
0.00 0.00 0.06 0.00
Operating Cash Flow to Interest Expense
0.00 0.00 11.97 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 0.00 10.91 0.00
Efficiency Ratios
- - - -
Asset Turnover
0.00 1.00 0.74 0.57
Accounts Receivable Turnover
0.00 1.41 1.64 1.59
Inventory Turnover
0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 125.95 163.51 26.98
Accounts Payable Turnover
0.00 4.92 6.23 7.90
Days Sales Outstanding (DSO)
0.00 258.25 222.29 228.98
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 74.15 58.61 46.23
Cash Conversion Cycle (CCC)
0.00 184.10 163.68 182.75
Capital & Investment Metrics
- - - -
Invested Capital
0.00 30 108 101
Invested Capital Turnover
0.00 21.49 5.35 3.28
Increase / (Decrease) in Invested Capital
0.00 30 78 -6.55
Enterprise Value (EV)
0.00 579 1,644 418
Market Capitalization
577 577 1,993 604
Book Value per Share
$0.00 $3.12 $14.93 $10.82
Tangible Book Value per Share
$0.00 $1.69 $14.40 $9.91
Total Capital
0.00 92 457 288
Total Debt
0.00 64 0.00 0.00
Total Long-Term Debt
0.00 64 0.00 0.00
Net Debt
0.00 1.86 -350 -187
Capital Expenditures (CapEx)
8.26 8.23 10 34
Debt-free, Cash-free Net Working Capital (DFCFNWC)
0.00 38 28 14
Debt-free Net Working Capital (DFNWC)
0.00 100 378 200
Net Working Capital (NWC)
0.00 100 378 200
Net Nonoperating Expense (NNE)
27 10 9.62 -3.88
Net Nonoperating Obligations (NNO)
0.00 1.86 -350 -187
Total Depreciation and Amortization (D&A)
8.89 9.97 9.14 8.47
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 11.75% 7.59% 3.96%
Debt-free Net Working Capital to Revenue
0.00% 31.31% 102.81% 58.46%
Net Working Capital to Revenue
0.00% 31.31% 102.81% 58.46%
Earnings Adjustments
- - - -
Adjusted Basic Earnings per Share
$0.00 $0.00 $2.85 $0.13
Adjusted Weighted Average Basic Shares Outstanding
0.00 0.00 24.12M 28.37M
Adjusted Diluted Earnings per Share
$0.00 $0.00 $2.56 $0.12
Adjusted Weighted Average Diluted Shares Outstanding
0.00 0.00 26.86M 30.10M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
0.00 0.00 31.02M 24.35M
Normalized Net Operating Profit after Tax (NOPAT)
-28 48 20 -0.59
Normalized NOPAT Margin
-13.39% 15.14% 5.32% -0.17%
Pre Tax Income Margin
-25.91% 13.76% 6.67% 2.88%
Debt Service Ratios
- - - -
EBIT to Interest Expense
0.00 0.00 2.56 0.00
NOPAT to Interest Expense
0.00 0.00 8.09 0.00
EBIT Less CapEx to Interest Expense
0.00 0.00 1.50 0.00
NOPAT Less CapEx to Interest Expense
0.00 0.00 7.04 0.00
Payout Ratios
- - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
-0.05% 1.71% 54.35% 6,516.67%

Quarterly Metrics And Ratios for Ibotta

This table displays calculated financial ratios and metrics derived from Ibotta's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026 9/30/2026
DEI Shares Outstanding
- - - - 31,022,388.00 28,447,773.00 28,398,786.00 - 24,350,180.00 23,274,969.00 23,169,614.00
DEI Adjusted Shares Outstanding
- - - - 31,022,388.00 28,447,773.00 28,398,786.00 - 24,350,180.00 23,274,969.00 23,169,614.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - 0.02 0.09 0.05 - -0.42 -0.05 -0.15
Growth Metrics
- - - - - - - - - - -
Revenue Growth
42.70% 13.62% 15.63% -1.30% 2.73% -2.16% -15.58% -10.02% -2.47% 3.34% 17.49%
EBITDA Growth
121,085.71% -194.17% 79.97% -43.18% -105.90% 117.90% -82.38% -94.63% -696.20% -58.97% 111.08%
EBIT Growth
680.90% -217.85% 121.08% -47.04% -122.54% 105.34% -86.75% -113.18% -239.26% -253.25% 72.65%
NOPAT Growth
1,908.74% -189.93% 21.22% 165.11% -127.01% 105.26% -95.14% -88.39% -135.42% -264.87% -493.75%
Net Income Growth
317.07% -321.41% 104.91% 308.52% -94.03% 107.33% -91.11% -101.32% -1,959.82% -149.36% -328.51%
EPS Growth
167.35% -327.59% 64.52% 198.04% -93.94% 106.06% -90.20% -100.99% -2,250.00% -162.50% -400.00%
Operating Cash Flow Growth
619.39% 2,260.39% 2,054.72% -7.10% 2.55% -26.17% -44.99% 26.46% 52.94% -48.72% 0.91%
Free Cash Flow Firm Growth
0.00% 0.00% 0.00% 0.00% -329.77% -6.80% -206.44% 167.55% 115.28% 114.47% 121.93%
Invested Capital Growth
0.00% 0.00% 0.00% 261.23% 247.36% 147.40% 189.65% -6.09% -18.66% -9.78% -16.78%
Revenue Q/Q Growth
0.00% 6.80% 12.16% -0.24% -14.03% 1.72% -3.22% 6.32% -6.83% 7.79% 10.03%
EBITDA Q/Q Growth
0.00% -222.53% 210.03% -34.82% -106.71% 471.77% 8.35% -80.14% -1,095.49% 119.16% 457.35%
EBIT Q/Q Growth
0.00% -262.44% 189.68% -37.44% -124.74% 138.48% 122.56% -162.22% -536.75% 82.62% 350.74%
NOPAT Q/Q Growth
0.00% -227.11% 193.71% 309.07% -105.54% 124.74% -13.34% 877.35% -212.34% 82.67% -106.96%
Net Income Q/Q Growth
0.00% -465.34% 150.75% 341.86% -99.27% 348.65% -38.43% -165.43% -929.11% 88.09% -185.03%
EPS Q/Q Growth
0.00% -500.00% 138.64% 496.08% -99.34% 300.00% -37.50% -160.00% -1,333.33% 88.37% -200.00%
Operating Cash Flow Q/Q Growth
0.00% 80.83% 12.92% -44.40% -9.67% 30.19% -15.86% 27.82% 9.24% -56.35% 65.58%
Free Cash Flow Firm Q/Q Growth
0.00% -217.76% 60.57% 12.39% -291.49% 21.04% -13.14% 119.31% -11.47% -25.22% 71.53%
Invested Capital Q/Q Growth
0.00% 40.11% -12.33% 193.30% -3.58% -0.21% 2.64% -4.91% -16.48% 10.69% -5.32%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
87.23% 86.03% 87.66% 84.60% 79.79% 79.16% 79.41% 78.65% 76.42% 78.42% 79.85%
EBITDA Margin
20.57% -23.60% 23.15% 15.13% -1.18% 4.32% 4.83% 0.90% -9.64% 1.71% 8.68%
Operating Margin
19.32% -24.63% 21.00% 13.18% -3.31% 1.44% 2.84% -1.85% -13.13% -2.11% 4.83%
EBIT Margin
17.25% -26.24% 20.98% 13.16% -3.79% 1.43% 3.29% -1.93% -13.17% -2.12% 4.84%
Profit (Net Income) Margin
11.29% -38.63% 17.48% 77.43% 0.66% 2.89% 1.84% -1.13% -12.51% -1.38% -3.58%
Tax Burden Percent
74.99% 113.11% 68.61% 448.07% 114.91% 64.37% 29.19% -411.07% 110.36% 231.02% -57.59%
Interest Burden Percent
87.29% 130.16% 121.44% 131.32% -15.08% 313.96% 191.54% -14.30% 86.10% 28.18% 128.50%
Effective Tax Rate
25.01% 0.00% 31.39% -348.07% -14.91% 35.63% 70.81% 511.07% 0.00% 0.00% 157.59%
Return on Invested Capital (ROIC)
0.00% 0.00% 0.00% 315.83% -21.06% 4.69% 4.09% 25.03% -33.26% -5.15% -10.22%
ROIC Less NNEP Spread (ROIC-NNEP)
0.00% 0.00% 0.00% 305.45% -23.49% 4.09% 3.79% 27.92% -32.07% -5.19% -9.80%
Return on Net Nonoperating Assets (RNNOA)
0.00% 0.00% 0.00% -218.97% 16.44% -3.26% -3.02% -20.10% 22.79% 3.48% 6.44%
Return on Equity (ROE)
0.00% 0.00% 0.00% 96.87% -4.62% 1.43% 1.06% 4.93% -10.46% -1.67% -3.78%
Cash Return on Invested Capital (CROIC)
0.00% 0.00% 0.00% 0.81% -44.79% 6.83% -38.86% 5.99% 6,280.29% 1.76% 11.39%
Operating Return on Assets (OROA)
0.00% 0.00% 0.00% 9.68% -2.91% 0.91% 1.99% -1.10% -8.01% -1.34% 3.26%
Return on Assets (ROA)
0.00% 0.00% 0.00% 56.97% 0.50% 1.84% 1.11% -0.64% -7.61% -0.87% -2.41%
Return on Common Equity (ROCE)
0.00% 0.00% 0.00% 96.87% -4.62% 1.43% 1.06% 4.93% -10.46% -1.67% -3.78%
Return on Equity Simple (ROE_SIMPLE)
0.00% 0.00% 0.00% 0.00% 14.95% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
12 -15 14 58 -3.22 0.80 0.69 6.75 -7.58 -1.31 -2.72
NOPAT Margin
14.49% -17.24% 14.41% 59.07% -3.81% 0.93% 0.83% 7.62% -9.19% -1.48% -2.78%
Net Nonoperating Expense Percent (NNEP)
-36.96% -11.83% 1.78% 10.38% 2.42% 0.60% 0.30% -2.89% -1.19% 0.04% -0.42%
Return On Investment Capital (ROIC_SIMPLE)
- - - 12.71% -0.80% 0.23% 0.21% 2.35% -3.05% -0.54% -1.14%
Cost of Revenue to Revenue
12.77% 13.97% 12.34% 15.40% 20.21% 20.84% 20.59% 21.35% 23.58% 21.58% 20.15%
SG&A Expenses to Revenue
15.98% 32.65% 20.92% 20.58% 25.29% 25.88% 26.98% 25.00% 28.81% 24.51% 23.23%
R&D to Revenue
16.57% 19.93% 16.51% 16.08% 21.36% 17.14% 16.84% 16.09% 17.58% 16.95% 16.57%
Operating Expenses to Revenue
67.91% 110.66% 66.66% 71.42% 83.10% 77.73% 76.57% 80.51% 89.55% 80.53% 75.03%
Earnings before Interest and Taxes (EBIT)
14 -23 21 13 -3.20 1.23 2.74 -1.71 -11 -1.89 4.73
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
17 -21 23 15 -1.00 3.71 4.02 0.80 -7.95 1.52 8.49
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
13.09 6.36 4.99 4.36 3.26 2.94 2.40 2.10 2.93 3.29 3.83
Price to Tangible Book Value (P/TBV)
19.12 6.63 5.21 4.52 3.41 3.11 2.57 2.29 3.28 3.29 3.83
Price to Revenue (P/Rev)
0.00 0.00 0.00 5.43 3.54 2.83 2.25 1.76 2.14 2.32 2.55
Price to Earnings (P/E)
0.00 0.00 0.00 29.00 21.82 10.79 9.79 169.01 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
0.00% 0.00% 0.00% 3.45% 4.58% 9.26% 10.21% 0.59% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
18.85 47.10 42.16 15.28 9.75 7.64 5.34 4.13 6.70 6.93 8.63
Enterprise Value to Revenue (EV/Rev)
0.00 0.00 0.00 4.48 2.74 2.15 1.61 1.22 1.66 1.89 2.13
Enterprise Value to EBITDA (EV/EBITDA)
0.00 0.00 0.00 48.48 63.36 19.55 26.25 55.40 969.43 0.00 266.50
Enterprise Value to EBIT (EV/EBIT)
0.00 0.00 0.00 66.36 137.39 24.97 41.38 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
0.00 0.00 0.00 20.97 23.01 11.86 13.58 0.00 0.10 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
0.00 0.00 0.00 14.18 8.69 7.37 6.34 4.38 5.34 6.94 8.17
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 0.00 0.00 2,952.61 0.00 159.23 0.00 66.83 0.10 373.61 68.83
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
1.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to Equity
1.48 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage
-0.32 -0.88 -0.90 -0.72 -0.70 -0.80 -0.80 -0.72 -0.71 -0.67 -0.66
Leverage Ratio
7.30 1.55 1.58 2.06 2.16 1.62 1.65 1.62 1.72 1.82 1.87
Compound Leverage Factor
6.38 2.01 1.92 2.70 -0.33 5.09 3.16 -0.23 1.48 0.51 2.41
Debt to Total Capital
59.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital
59.68% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
40.32% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00%
Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to EBITDA
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Long-Term Debt to NOPAT
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score
0.96 7.01 5.48 6.39 4.18 3.39 2.80 2.25 2.50 2.60 2.84
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.65 2.81 2.72 2.85 2.69 2.37 2.21 1.96 1.80 1.71 1.67
Quick Ratio
1.57 2.77 2.69 2.79 2.56 2.25 2.11 1.90 1.73 1.65 1.65
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-18 -57 -22 -20 -77 -61 -69 13 12 8.81 15
Operating Cash Flow to CapEx
785.00% 1,508.18% 1,379.28% 863.93% 399.76% 369.36% 194.93% 248.81% 430.17% 254.77% 424.44%
Free Cash Flow to Firm to Interest Expense
0.00 -5.92 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense
0.00 3.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense
0.00 3.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.00 0.00 0.00 0.74 0.77 0.64 0.60 0.57 0.61 0.63 0.67
Accounts Receivable Turnover
0.00 0.00 0.00 1.64 1.79 1.76 1.60 1.59 1.75 1.66 1.65
Inventory Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
0.00 0.00 0.00 163.51 108.26 64.97 32.56 26.98 24.61 21.28 16.91
Accounts Payable Turnover
0.00 0.00 0.00 6.23 5.98 7.88 5.71 7.90 7.92 8.34 6.69
Days Sales Outstanding (DSO)
0.00 0.00 0.00 222.29 203.78 207.52 228.29 228.98 208.73 219.30 221.58
Days Inventory Outstanding (DIO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)
0.00 0.00 0.00 58.61 61.09 46.35 63.88 46.23 46.09 43.75 54.53
Cash Conversion Cycle (CCC)
0.00 0.00 0.00 163.68 142.70 161.17 164.40 182.75 162.64 175.55 167.05
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
30 42 37 108 104 104 106 101 84 93 88
Invested Capital Turnover
0.00 0.00 0.00 5.35 5.53 5.06 4.93 3.28 3.62 3.49 3.68
Increase / (Decrease) in Invested Capital
30 42 37 78 74 62 70 -6.55 -19 -10 -18
Enterprise Value (EV)
563 1,971 1,546 1,644 1,012 791 568 418 565 647 763
Market Capitalization
577 2,289 1,888 1,993 1,309 1,041 791 604 730 795 913
Book Value per Share
$4.74 $11.81 $12.34 $14.93 $12.94 $12.45 $11.61 $10.82 $10.22 $10.38 $10.29
Tangible Book Value per Share
$3.24 $11.34 $11.83 $14.40 $12.37 $11.78 $10.82 $9.91 $9.14 $10.38 $10.29
Total Capital
109 360 378 457 401 354 330 288 249 242 238
Total Debt
65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Long-Term Debt
65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt
-14 -318 -341 -350 -298 -251 -223 -187 -165 -148 -150
Capital Expenditures (CapEx)
2.47 2.32 2.87 2.55 4.97 7.00 11 11 7.06 5.20 5.17
Debt-free, Cash-free Net Working Capital (DFCFNWC)
39 26 23 28 34 28 26 14 -4.52 3.99 1.90
Debt-free Net Working Capital (DFNWC)
118 344 365 378 331 279 249 200 160 152 152
Net Working Capital (NWC)
118 344 365 378 331 279 249 200 160 152 152
Net Nonoperating Expense (NNE)
2.63 19 -3.03 -18 -3.78 -1.69 -0.84 7.75 2.74 -0.08 0.78
Net Nonoperating Obligations (NNO)
-14 -318 -341 -350 -298 -251 -223 -187 -165 -148 -150
Total Depreciation and Amortization (D&A)
2.74 2.32 2.14 1.94 2.20 2.48 1.28 2.51 2.91 3.41 3.76
Debt-free, Cash-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 7.59% 9.19% 7.62% 7.26% 3.96% -1.33% 1.16% 0.53%
Debt-free Net Working Capital to Revenue
0.00% 0.00% 0.00% 102.81% 89.71% 75.79% 70.67% 58.46% 47.04% 44.34% 42.43%
Net Working Capital to Revenue
0.00% 0.00% 0.00% 102.81% 89.71% 75.79% 70.67% 58.46% 47.04% 44.34% 42.43%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.00 ($1.32) $0.56 $2.61 $0.02 $0.09 $0.05 ($0.03) ($0.43) ($0.05) ($0.15)
Adjusted Weighted Average Basic Shares Outstanding
9.31M 25.66M 30.66M 24.12M 30.78M 28.48M 28.00M 28.37M 24.15M 23.28M 23.35M
Adjusted Diluted Earnings per Share
$0.33 ($1.32) $0.51 $3.04 $0.02 $0.08 $0.05 ($0.03) ($0.43) ($0.05) ($0.15)
Adjusted Weighted Average Diluted Shares Outstanding
28.36M 25.66M 33.57M 26.86M 33.22M 30.43M 29.38M 30.10M 24.15M 23.28M 23.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
30.45M 30.64M 30.63M 31.02M 28.45M 28.40M 26.58M 24.35M 23.27M 23.17M 23.43M
Normalized Net Operating Profit after Tax (NOPAT)
12 -15 14 9.08 -1.96 0.80 1.66 -1.15 -7.58 -1.31 3.31
Normalized NOPAT Margin
14.49% -17.24% 14.41% 9.23% -2.32% 0.93% 1.99% -1.30% -9.19% -1.48% 3.38%
Pre Tax Income Margin
15.06% -34.15% 25.48% 17.28% 0.57% 4.50% 6.31% 0.28% -11.34% -0.60% 6.22%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
0.00 -2.40 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense
0.00 -1.57 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense
0.00 -2.64 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense
0.00 -1.82 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 54.35% 175.73% 178.21% 240.19% 6,516.67% -2,848.88% -1,484.25% -868.57%

Financials Breakdown Chart

Key Financial Trends

Ibotta’s recent financial statements show a business with solid gross margins and positive operating cash flow, but weakening revenue momentum, recurring GAAP losses and a significantly smaller cash cushion. The company’s financial profile has also been affected by substantial share repurchases and accounting restatements.

  • Revenue remains well above early-2023 levels. Quarterly revenue increased from $57.7 million in Q1 2023 to $88.9 million in Q2 2026, representing approximately 54% growth over that period. However, revenue has declined from the nearly $100 million quarterly levels reported in late 2023 and 2024.
  • Gross margins remain strong. Ibotta generated $69.7 million of gross profit on $88.9 million of revenue in Q2 2026, a gross margin of approximately 78.4%. This indicates that the company’s core offering continues to produce substantial gross profit before operating expenses.
  • Operating cash flow remains positive. Ibotta generated $13.3 million of cash from operations in Q2 2026, following $30.4 million in Q1 2026 and $25.9 million in Q2 2025. Positive operating cash flow provides some support despite the company’s GAAP losses.
  • The balance sheet carries no reported long-term debt. Ibotta had $148.2 million of cash and equivalents at June 30, 2026, compared with $243.8 million of total liabilities. The absence of reported long-term debt limits interest-rate and refinancing risk.
  • Share repurchases have reduced the share base. Weighted-average basic shares fell from 30.8 million in Q1 2025 to 23.3 million in Q2 2026. If earnings recover, fewer shares outstanding could improve earnings per share for continuing shareholders.
  • Liquidity remains adequate but is trending lower. Cash and equivalents declined from $341.3 million in Q3 2024 and $250.5 million in Q2 2025 to $148.2 million in Q2 2026. Current assets of $365.6 million exceeded current liabilities of $213.5 million, but the shrinking cash balance bears monitoring.
  • Accounts receivable remains a large balance-sheet item. Accounts receivable increased to $203.4 million in Q2 2026 from $183.1 million in Q1 2026. Investors should watch collections and working-capital trends because receivables are larger than the company’s cash balance.
  • Profitability has deteriorated sharply. Ibotta reported operating losses of $10.8 million in Q1 2026 and $1.9 million in Q2 2026, compared with operating income of $1.2 million in Q2 2025 and $2.4 million in Q3 2025. Q2’s net loss narrowed to $1.2 million from $10.3 million in Q1, but the company remains unprofitable.
  • Operating expenses continue to consume nearly all gross profit. Q2 2026 operating expenses totaled $72.0 million, exceeding the $69.7 million gross profit. Marketing expense alone was $32.9 million, while selling, general and administrative expense was $21.8 million and research and development expense was $15.1 million.
  • Cash usage from financing has been substantial. Ibotta repurchased $25.0 million of stock in Q2 2026 and $44.8 million in Q1 2026, following $54.8 million in Q4 2025 and $38.0 million in Q3 2025. These repurchases contributed to quarterly cash declines and helped reduce total equity to $241.6 million from $354.1 million in Q2 2025.

Overall, Ibotta’s strongest financial characteristics are its high gross margin, positive operating cash flow and debt-free balance sheet. The primary concerns are declining revenue from prior peaks, renewed operating losses, heavy marketing spending and the rapid reduction in cash caused partly by buybacks. Investors will likely want to see sustained revenue growth and operating profitability before treating the recent improvement in Q2 2026 as a durable turnaround.

11/17/26 02:12 AM ETAI Generated. May Contain Errors.

Ibotta Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Ibotta's fiscal year ends in December. Their fiscal year 2025 ended on December 31, 2025.

Ibotta's net income appears to be on an upward trend, with a most recent value of $3.58 million in 2025, compared with -$54.86 million in 2022. The previous period was $68.74 million in 2024. View Ibotta's forecast to see where analysts expect Ibotta to go next.

Ibotta's total operating income in 2025 was -$841 thousand, based on the following breakdown:
  • Total Gross Profit: $271.33 million
  • Total Operating Expenses: $272.18 million

Over the last 3 years, Ibotta's total revenue changed from $210.70 million in 2022 to $342.39 million in 2025, a change of 62.5%.

In the past 10 quarters, Ibotta's cash and equivalents has ranged from $79.50 million in Q1 2024 to $341.27 million in Q3 2024, and is currently $149.89 million as of their latest financial filing in Q3 2026.

Ibotta had total debt of $0.00 at the end of 2025, compared with none in 2024, and none in 2022.

Over the last 3 years, Ibotta's book value per share changed from 0.00 in 2022 to 10.82 in 2025, a change of 1,082.1%.



Financial statements for NYSE:IBTA last updated on 11/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners